Clinical Trials in Garmisch-Partenkirchen, Germany
Locations / Garmisch-Partenkirchen, Germany
Delta Trials records 67 clinical trials conducted in Garmisch-Partenkirchen, Germany, making it a notable site of clinical research activity. These trials across 63 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 4 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Garmisch-Partenkirchen has changed over time.
67
Total Trials
63
Conditions
4
Terminated since 2020
Browse by condition (63 total)
- Venous thromboembolism 5 trialsAll Venous thromboembolism trials
- Chronic lymphocytic leukemia 5 trialsAll Chronic lymphocytic leukemia trials
- Thromboembolism 4 trialsAll Thromboembolism trials
- All Pulmonary disease, chronic obstructive trials
- All Chronic obstructive pulmonary disease trials
- Gastroesophageal reflux 2 trialsAll Gastroesophageal reflux trials
- Prevention 2 trialsAll Prevention trials
- COPD 2 trialsAll COPD trials
- Myocardial infarction 2 trialsAll Myocardial infarction trials
- Severe chronic pain 2 trialsAll Severe chronic pain trials
- Juvenile idiopathic arthritis 2 trialsAll Juvenile idiopathic arthritis trials
- Leukemia 2 trialsAll Leukemia trials
- Lymphoma 2 trialsAll Lymphoma trials
- Osteoarthritis 2 trialsAll Osteoarthritis trials
- Gastroesophageal reflux disease 2 trialsAll Gastroesophageal reflux disease trials
- Coronary artery disease 2 trialsAll Coronary artery disease trials
- Ejaculation 1 trialAll Ejaculation trials
- Renal failure 1 trialAll Renal failure trials
- Neoplasms, breast 1 trialAll Neoplasms, breast trials
- Hypertension 1 trialAll Hypertension trials